131 related articles for article (PubMed ID: 22633812)
1. Prospective analysis of patient-reported late toxicity following pelvic radiotherapy for gynaecological cancer.
Barraclough LH; Routledge JA; Farnell DJ; Burns MP; Swindell R; Livsey JE; Davidson SE
Radiother Oncol; 2012 Jun; 103(3):327-32. PubMed ID: 22633812
[TBL] [Abstract][Full Text] [Related]
2. Self-reported symptoms of faecal incontinence among long-term gynaecological cancer survivors and population-based controls.
Dunberger G; Lind H; Steineck G; Waldenström AC; Nyberg T; Al-Abany M; Nyberg U; Vall-Lundqvist E
Eur J Cancer; 2010 Feb; 46(3):606-15. PubMed ID: 19926277
[TBL] [Abstract][Full Text] [Related]
3. Late patient-reported toxicity after preoperative radiotherapy or chemoradiotherapy in nonresectable rectal cancer: results from a randomized Phase III study.
Brændengen M; Tveit KM; Bruheim K; Cvancarova M; Berglund Å; Glimelius B
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1017-24. PubMed ID: 20932687
[TBL] [Abstract][Full Text] [Related]
4. Patient-reported lower urinary tract symptoms, urinary incontinence, and quality of life after external beam radiotherapy for localized prostate cancer--15 years' follow-up. A comparison with age-matched controls.
Fransson P
Acta Oncol; 2008; 47(5):852-61. PubMed ID: 17899451
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of data capture for patient-reported toxicity following radiotherapy for prostate or cervical cancer.
Farnell DJ; Routledge J; Hannon R; Logue JP; Cowan RA; Wylie JP; Barraclough LH; Livsey JE; Swindell R; Davidson SE
Eur J Cancer; 2010 Feb; 46(3):534-40. PubMed ID: 20022742
[TBL] [Abstract][Full Text] [Related]
6. A modified inflammatory bowel disease questionnaire and the Vaizey Incontinence questionnaire are more sensitive measures of acute gastrointestinal toxicity during pelvic radiotherapy than RTOG grading.
Khalid U; McGough C; Hackett C; Blake P; Harrington KJ; Khoo VS; Tait D; Norman AR; Andreyev HJ
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1432-41. PubMed ID: 16580497
[TBL] [Abstract][Full Text] [Related]
7. [Late effects following curative radiotherapy for prostate cancer].
Fokdal LU; Høyer M
Ugeskr Laeger; 2005 Sep; 167(37):3502-7. PubMed ID: 16159460
[TBL] [Abstract][Full Text] [Related]
8. Late side effects and quality of life after radiotherapy for rectal cancer.
Bruheim K; Guren MG; Skovlund E; Hjermstad MJ; Dahl O; Frykholm G; Carlsen E; Tveit KM
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1005-11. PubMed ID: 19540058
[TBL] [Abstract][Full Text] [Related]
9. Impact of functional results on quality of life after rectal cancer surgery.
Vironen JH; Kairaluoma M; Aalto AM; Kellokumpu IH
Dis Colon Rectum; 2006 May; 49(5):568-78. PubMed ID: 16583289
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and tolerability of colesevelam hydrochloride for bile-acid malabsorption in patients with cancer: a retrospective chart review and patient questionnaire.
Wedlake L; Thomas K; Lalji A; Anagnostopoulos C; Andreyev HJ
Clin Ther; 2009 Nov; 31(11):2549-58. PubMed ID: 20109999
[TBL] [Abstract][Full Text] [Related]
11. Combined curative radiotherapy including HDR brachytherapy and androgen deprivation in localized prostate cancer: a prospective assessment of acute and late treatment toxicity.
Wahlgren T; Nilsson S; Ryberg M; Lennernäs B; Brandberg Y
Acta Oncol; 2005; 44(6):633-43. PubMed ID: 16165923
[TBL] [Abstract][Full Text] [Related]
12. Small bowel bacterial overgrowth and lactose intolerance during radical pelvic radiotherapy: An observational study.
Wedlake L; Thomas K; McGough C; Andreyev HJ
Eur J Cancer; 2008 Oct; 44(15):2212-7. PubMed ID: 18760593
[TBL] [Abstract][Full Text] [Related]
13. Predicting late effects of pelvic radiotherapy: is there a better approach?
Wedlake LJ; Thomas K; Lalji A; Blake P; Khoo VS; Tait D; Andreyev HJ
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1163-70. PubMed ID: 20231077
[TBL] [Abstract][Full Text] [Related]
14. Quality of life and adverse events after radiotherapy in gynecologic cancer survivors: a cohort study.
Vaz AF; Conde DM; Costa-Paiva L; Morais SS; Esteves SB; Pinto-Neto AM
Arch Gynecol Obstet; 2011 Dec; 284(6):1523-31. PubMed ID: 21442259
[TBL] [Abstract][Full Text] [Related]
15. Developing a CTCAEs patient questionnaire for late toxicity after head and neck radiotherapy.
Ho KF; Farnell DJ; Routledge JA; Burns MP; Sykes AJ; Slevin NJ; Davidson SE
Eur J Cancer; 2009 Jul; 45(11):1992-8. PubMed ID: 19427196
[TBL] [Abstract][Full Text] [Related]
16. Quality of life and menopausal and sexual symptoms in gynecologic cancer survivors: a cohort study.
Vaz AF; Pinto-Neto AM; Conde DM; Costa-Paiva L; Morais SS; Pedro AO; Esteves SB
Menopause; 2011 Jun; 18(6):662-9. PubMed ID: 21471827
[TBL] [Abstract][Full Text] [Related]
17. Long-term anorectal, urinary and sexual dysfunction causing distress after radiotherapy for anal cancer: a Danish multicentre cross-sectional questionnaire study.
Sunesen KG; Nørgaard M; Lundby L; Havsteen H; Buntzen S; Thorlacius-Ussing O; Laurberg S
Colorectal Dis; 2015 Nov; 17(11):O230-9. PubMed ID: 26218674
[TBL] [Abstract][Full Text] [Related]
18. A longitudinal assessment of bowel related symptoms and fecal incontinence following radical perineal prostatectomy.
Dahm P; Silverstein AD; Weizer AZ; Young MD; Vieweg J; Albala DM; Paulson DF
J Urol; 2003 Jun; 169(6):2220-4. PubMed ID: 12771754
[TBL] [Abstract][Full Text] [Related]
19. Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial.
Nout RA; Putter H; Jürgenliemk-Schulz IM; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; Mens JW; Slot A; Stenfert Kroese MC; van Bunningen BN; Smit VT; Nijman HW; van den Tol PP; Creutzberg CL
J Clin Oncol; 2009 Jul; 27(21):3547-56. PubMed ID: 19546404
[TBL] [Abstract][Full Text] [Related]
20. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study.
Peeters KC; van de Velde CJ; Leer JW; Martijn H; Junggeburt JM; Kranenbarg EK; Steup WH; Wiggers T; Rutten HJ; Marijnen CA
J Clin Oncol; 2005 Sep; 23(25):6199-206. PubMed ID: 16135487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
